The relationship between metformin and serum prostate ‐specific antigen levels

CONCLUSIONSMetformin dose‐dependently inversely associated with serum PSA, independent of other antihyperglycemic medications. Whether metformin confers a dose‐dependent benefit on prostate tumorigenesis and progression warrants investigation. Prostate © 2016 The Authors. The Prostate published by Wiley Periodicals, Inc.

Source: The Prostate - July 11, 2016 Category: Urology & Nephrology Authors: Viranda H. Jayalath, Christopher Ireland, Neil E. Fleshner, Robert J. Hamilton, David J.A. Jenkins Tags: Original Article Source Type: research